Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema - 26/08/11
, Ingrid Kreissig, MD a, Robert F. Degenring, MD aAbstract |
Purpose |
To report the clinical outcome of patients undergoing intravitreal injection of triamcinolone acetonide as treatment of long-standing cystoid macular edema after phacoemulsification.
Design |
Prospective clinical interventional cases series studies.
Methods |
The study included five patients suffering from cystoid macular edema after cataract surgery. They received an intravitreal injection of 25-mg crystalline triamcinolone acetonide transconjunctivally with topical anesthesia.
Results |
In the follow-up period of 6.6 ± 4.1 months, visual acuity increased from 0.26 ± 0.13 to a mean maximal visual acuity of 0.60 ± 0.19. For all patients, visual acuity improved during the follow-up by at least 0.20. Two (40%) patients developed intraocular pressure values higher than 21 mm Hg, which could be controlled by topical antiglaucomatous treatment.
Conclusions |
Intravitreal triamcinolone acetonide may be a therapeutic option for long-standing cystoid macular edema after cataract surgery.
Le texte complet de cet article est disponible en PDF. | InternetAdvance publication at ajo.com June 13, 2003. |
Vol 136 - N° 2
P. 384-386 - août 2003 Retour au numéro
Article précédent
- Subluxation of transscleral sutured posterior chamber intraocular lens (TSIOL)
- Jeehee Kim, James L. Kinyoun, David A. Saperstein, Stacy L. Porter
- Cytomegalovirus retinitis and FK 506
- Antonio P. Ciardella, Gaetano Barile, Kevin Langton, Stanley Chang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?